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Abstract. Previously, a high affinity, glycosylphos- 
phatidylinositol-anchored receptor for folate and a ca- 
veolae internalization cycle have been found necessary 
for potocytosis of 5-methyltetrahydrofolate in MA104. 
We now show by cell fractionation that folate receptors 
also must be clustered in caveolae for potocytosis. An 
enriched fraction of caveolae from control cells re- 
tained 65-70% of the [3H]folic acid bound to cells in 
culture. Exposure of cells to the cholesterol-binding 
drug, filipin, which is known to uncluster receptors, 
shifted ~50% of the bound [3H]folic acid from the ca- 
veolae fraction to the noncaveolae membrane fraction 
and markedly inhibited internalization of [3H]folic acid. 
An mAb directed against the folate receptor also 
shifted ~50% of the caveolae-associated [3H]folic acid 
to noncaveolae membrane, indicating the antibody per- 
turbs the normal receptor distribution. Concordantly, 
the mAb inhibited the delivery of 5-methyl[3H]tetrahy  - 
drofolate to the cytoplasm. Receptor bound 5-me- 
thyl[3H]tetrahydrofolate moved directly from caveolae 
to the cytoplasm and was not blocked by phenylarsine 
oxide, an inhibitor of receptor-mediated endocytosis. 
These results suggest cell fractionation can be used to 
study the uptake of molecules by caveolae. 
T 
HERE is now considerable evidence that the recep- 
tor-mediated delivery of 5-methyltetrahydrofolate 
to the cell cytoplasm occurs by a unique endocytic 
pathway called potocytosis (4). First, the folate receptor is 
anchored  by  glycosylphosphatidylinositol (GPI)  1 rather 
than a  transmembrane domain and localizes to caveolae 
instead  of clathrin-coated pits  (24).  Second,  transfer of 
membrane-bound  5-methyltetrahydrofolate to  the  cyto- 
plasm appears to occur from a compartment that is associ- 
ated with the plasma membrane rather than from an inter- 
nal, endosomal compartment (11-13). Third, the kinetics 
of folate receptor recycling are  distinctly different from 
those receptors that recycle using clathrin-coated pits (11). 
Fourth, inhibition of caveolae internalization either by de- 
pleting  membrane  cholesterol (6),  treatment  with  PMA 
(29),  or  exposure  to  histamine  (31)  specifically  blocks 
5-methyltetrahydrofolate uptake.  Finally, chimeric folate 
receptors that contain a coated pit targeting sequence de- 
liver folate to the cytoplasm less efficiently than normal 
receptors  and,  in  addition,  lack  the  ability  to  regulate 
folate accumulation (22). 
Several aspects of the potocytosis pathway remain un- 
clear because there is not a ligand suitable for visualizing 
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the  internalization  step  with  the  electron  microscope. 
Without this  tool, investigators must  rely on immunocy- 
tochemistry  for  information  about  the  distribution  of 
folate receptors (18, 24). After the application of primary 
and secondary antibodies, the folate receptor is clearly as- 
sociated  with  caveolae.  There  is  disagreement  about 
whether the antibodies induce the migration of these mol- 
ecules into caveolae (18)  or, instead, detect their native 
distribution  (24).  Without an EM  marker, it is  also not 
possible to determine the mechanism of sequestration. Do 
caveolae actually bud from the membrane and form a ves- 
icle that migrates to other compartments in the cell or do 
they remain  associated  with  the  plasma  membrane  and 
close transiently during internalization? 
Another way to obtain basic information about the ca- 
veolae membrane traffic pattern, and potocytosis in gen- 
eral, is  to  use cell fractionation. This approach has pro- 
vided  critical  information  about  membrane  recycling 
during receptor-mediated endocytosis (1). Initially, caveo- 
lae were isolated from tissue-culture cells by taking advan- 
tage  of the  Triton X-100  insolubility of this  membrane 
(26). While  this  method continues to be a  valuable tool 
(16,  31), Triton X-100 can remove resident proteins from 
caveolae (7). A  new purification scheme circumvents the 
use of detergents (32) and has the added advantage that 
one can follow bound ligands  (32) and enzyme activities 
(28)  associated with this membrane. We have now used 
this method to study the internalization process. The re- 
suits suggest that ~70%  of folate receptors are naturally 
clustered  on  the  cell surface.  Incubation  of cells  in  the 
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clustering of half of these receptors and inhibits the deliv- 
ery of 5-methyltetrahydrofolate to the cytoplasm. In addi- 
tion, open caveolae (external folate receptors) and closed 
caveolae (internal receptors) are always in the same cav- 
eolae  fraction isolated  from the  plasma membrane.  Cell 
fractionation promises to be a  valuable tool for studying 
potocytosis in many different cells and tissues. 
Materials and Methods 
Materials 
Medium 199 with Earle's salts minus folic acid was prepared by standard 
methods. FCS was from Hazleton Research Products, Inc. (Lenexa, KS). 
Glutamine,  trypsin-EDTA,  and  penicillin/streptomycin  were  from 
GIBCO  BRL  (Gaithersburg, MD).  Percoll  was from  Pharmacia  Fine 
Chemicals (Piscataway,  NJ). OptiPrep was from GIBCO BRL [3H]folic 
acid  (sp act 27 Ci/mmol) and 5-[3H]methyltetrahydrofolate (sp act 21 Ci/ 
mmol) were purchased from Moravek Biochemicals (Brea, CA). 125I-di- 
ferric transferrin (human) (sp act 0.78 i~Ci/jxg) was purchased from Du- 
Pont-New England Nuclear (Wilmington, DE). Antibodies were obtained 
from the  following sources: anti-caveolin  IgG from Transduction Labs 
(Lexington,  KY);  anti-folate  receptor  IgG  (mAb, Movl8)  and  (mAb, 
Movl 9) from Centacor Corp. (Malvern, PA); rabbit anti-mouse IgG from 
Zymed Laboratories, Inc. (South San Francisco, CA). The anti-clathrin 
IgG was developed in the laboratory. The phenylarsine oxide and unla- 
beled transferrin were from Sigma Chemical Co. (St. Louis, MO). 
Buffers. Buffer A: 0.25 M sucrose, 1 mM EDTA, 20 mM tricine,  pH 7.8; 
buffer B: 0.25 M sucrose, 6 mM EDTA, 120 mM Tricine, pH 7.8; buffer C: 
50% OptiPrep in buffer B. 
Methods 
Cell Culture. The monkey kidney epithelial  cell line,  MA104,  was grown 
as a monolayer in folate-free medium 199 supplemented with 5% (vol/vol) 
FCS and 100 U/ml penicillin/streptomycin. Cells for each experiment were 
set up according to a standard format. On day 0, cells were seeded into T-25 
(1.5 ×  105 cells) or T-75 (3 x  105 cells) culture flasks and cultured for 5 d 
without further feeding.  For folate-binding studies, the medium was re- 
placed with folate-free M199 containing 20 mM Hepes (pH 7.4) without 
serum, and additions were made directly to the culture flasks. 
Purification of Caveolae. The caveolae isolation procedure was a modi- 
fication  of the method developed by Smart et al. (32). All steps were car- 
ried out at 4°C. Purified plasma membranes were prepared from 10 100-mm 
dishes or T-75 flasks of confluent tissue-culture cells (8-10 mg of total pro- 
tein) by Percoll  gradient centrifugation. Each dish/flask was washed twice 
with 5 ml of buffer A, and the cells were collected  by scraping in 3 ml of 
buffer A. The cells were pelleted by centrifugation for 5 min at 1,400 g in 
an  IEC Centra-4B  centrifuge  (International Equipment Co.,  Needham 
Heights, MA). The cells were resuspended in 1.0 ml of buffer A, placed in 
a 2-ml tissue grinder (No. 0841416A; Wheaton Instruments, Millville, N  J), 
and homogenized with 20 strokes of the teflon homogenizer. We trans- 
ferred the suspension to a 1.5-ml centrifuge tube and centrifuged at 1,000 g 
for 10 min in an Eppendorf 5415C centrifuge (Eppendorf North Ameri- 
can, Inc., Madison, WI). The postnuclear supernatant fraction (PNS) was 
removed and stored on ice. The pellet from each tube was resuspended in 
1.0 ml of buffer A, homogenized, and centrifuged at 1,000 g for 10 min 
again. The two post nuclear supernatant fractions were combined (~4 mg 
of total protein), layered on the top of 23 ml of 30% Percoll  in buffer A, 
and centrifuged at 84,000 g for 30 min in a rotor (Ti 60; Beckman Instru- 
ments, Inc., Palo Alto, CA). The plasma membrane fraction was a visible 
band ~5.7 cm from the bottom of the centrifuge bottle. The membrane 
fraction, which contained ~0.6 mg of protein, was collected  with a Pasteur 
pipette, adjusted to 2.0 ml with buffer A, and placed in a centrifuge tube 
(TH641;  Sorvall  Instruments Division, DuPont Co., Newton, CT) on ice. 
We placed a 3-mm-diam sonication probe equidistant from the bottom of 
the tube and the top of the solution and sonicated the sample six succes- 
sive times (total power of 50 1 each time), using the automatic settings of a 
Vibra Cell  sonicator (model VC60S;  Sonics & Materials Inc., Danbury, 
CT.).  An aliquot of the sonicate was saved before mixing the remainder 
with 1.84 mt of buffer C and 0.16 ml of buffer A (final  OptiPrep concen- 
tration, 23%) in the bottom of the same TH641  tube. A  linear 20-10% 
OptiPrep gradient (6 ml) (prepared by diluting buffer C with buffer A) 
was poured on top of the sample, and then centrifuged at 52,000 g, for 90 
min in a Sorvall  TH641  swinging bucket rotor. The top 5 ml of the gradi- 
ent (fractions 1 to 7) was collected,  placed  in  a fresh TH641  centrifuge 
tube, and mixed with 4 ml of buffer C. The sample was overlaid with 1 ml 
of 15% OptiPrep and 0.5 ml of 5% OptiPrep (prepared by diluting buffer 
C with buffer A) and centrifuged at 52,000 g for 90 rain at 4°C. A distinct 
opaque band was present at both interfaces.  The band at the 5 % interface 
was collected  and designated caveolar membranes. Typically, we obtained 
10-20 Ixg of protein in this band. 
Folate Receptor Sequestration. A  standard [3H]folic acid  binding assay 
was used to measure internal and external folate receptors (10). After the 
indicated  treatments, MA104 cells were incubated in the presence of 5 nM 
[3H]folic acid for 1 h at 37°C. External [3H]folic acid corresponded to the 
amount released when ceUs were incubated on ice for 30 s in the presence 
of acid saline (0.15 M NaCI, adjusted to pH 3.0 with glacial acetic acid). In- 
ternal folate was the amount of [3H]folic acid  that  remained associated 
with the acid saline-treated cells. The latter was collected  by adding 0.1  N 
NaOH to the flask  to dissolve  the cells.  Radioactivity  was measured by 
liquid  scintillation  counting using a liquid  scintillation  analyzer (Tri-carb 
1900A;  Packard  Instrument Co.,  Inc.,  Downers Grove, IL). Nonspecific 
binding, which was measured by adding  100-fold  excess unlabeled folic 
acid, was <5% of specific binding. 
Transferrin Uptake. MAI04 cells  were washed once with PBS before 
1.5 ml of Ml99 medium containing 20 mM Hepes (pH 7.4) was added to 
each flask.  Cells were preincubated in the presence or absence of PMA 
(1 txM) or phenylarsine oxide (20 tzM) for 30 min at 4°C. 125I-transferrin 
(0.32 ~g/ml, sp act 0.25 p.Ci/ml) was added to each dish, and the cells were 
incubated at 37°C for the indicated  time. The flasks were chilled on ice for 
20 min, and 1.5 ml of lysis buffer (10 mM Tris, pH 8.0, containing 1 IxM 
unlabeled transferrin) was added  to each flask.  The cells were placed at 
-80°C for 15 min and thawed on ice. The suspension was collected,  and 
the flask was washed with 1.0 ml of lysis buffer at 4°C. The two were com- 
bined and centrifuged for 20 rain at 100,000 g to separate the membrane 
(pellet) from the cytosol (supernatant). The radioactivity  in each was mea- 
sured  in  a  gamma counter.  Nonspecific binding of 1251-transferrin was 
<20%, 
To measure the migration of transferrin to internal  membrane com- 
partments, cells were incubated in the presence of ~2sI-transferrin as de- 
scribed above before preparing a postnuclear fraction and separating cy- 
tosol, plasma membrane, and internal membranes on Percoll  gradients. 
The cytosol fraction corresponded to the top 2 ml of the gradient, while 
the plasma membrane fraction was the visible band in fraction 4. The re- 
maining fractions,  which  contained  the  intracellular  membranes, were 
pooled and centrifuged at 185,000g for 1.5 h at 4°C to obtain a pellet. 
ElectrophoresisandImmunoblots.  Protein  concentrations  were  deter- 
mined by the  Bradford  assay (Bio Rad  Laboratories, Richmond, CA). 
Proteins were concentrated by TCA precipitation, washed in acetone, and 
resuspended in distilled  water before the addition of 5x Laemmli sample 
buffer and heating at 95°C for 2 rain.  Protein samples were loaded onto 
12.5 % SDS polyacrylamide gels and separated by the method of Laemmli 
(15)  before  transferring to  polyvinylidene  ditluoride  membranes. The 
membrane was blocked in TBST (20  mM Tris,  pH 7.6, 137  mM NaC1. 
0.5%  Tween-20) plus 5% dry milk for 1 h at room temperature. Primary 
antibodies were diluted in TBST +  1% dry milk and added to the incuba- 
tion mixture for 1 h at room temperature. After the primary antibody in- 
cubation, the membrane was washed four times, 10 rain each in TBST + 
1% dry milk. The appropriate secondary antibody conjugated to HRP was 
diluted 1:30,000 and added to the incubation mixture for 1 h at room tem- 
perature. The membrane was then washed and processed to visualize  re- 
active proteins by the chemiluminescence method. 
Quantification. For the folate receptor sequestration, 5-methyltetrahy- 
drofotate uptake and transferrin uptake experiments, ligand  binding was 
determined either by liquid  scintillation  or a gamma radiation counting. 
Each time point had three to six independent determinations per experi- 
ment. In addition, each experiment was conducted at least three times. Al- 
though the  absolute  numbers varied  between  experiments, the  results 
were always  the same. Representative experiments are shown. For the 
quantification  of radiation  in  the  different  OptiPrep  1 gradients, 50  jxl 
from each fraction was measured. Each fractionation experiment was con- 
ducted at least four times with similar results. 
Results 
A  membrane receptor is said to be clustered when mor- 
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area of the  cell surface (3).  The  isolated region of mem- 
brane  also contains a  high  concentration  of the receptor 
relative to  the  remainder of the  plasma membrane  (19). 
Previously, we used immunoblotting to show that the ca- 
veolae fraction  isolated from  MA104 cells is enriched in 
folate receptors (32).  A  more quantitative method for as- 
sessing enrichment is to measure the amount of receptor- 
bound  [3H]folic acid  in  the  caveolae fraction.  Folic acid 
binds  with  such  a  high  affinity that  it  cannot  dissociate 
from the receptor and move to the cytoplasm of the cell af- 
ter internalization (11). Folate-depleted MA104 cells were 
incubated in the presence of 5 nM [3H]folic acid for 1 h  at 
37°C  to label both internal and external folate receptors. 
Isolated plasma  membranes,  which  contained  all of the 
cell-associated  [3H]folic  acid,  were  sonicated  and  sepa- 
rated on the first of the two OptiPrep gradients used to pu- 
rify caveolae (Fig. 1 A). The gradient was divided into fif- 
teen fractions, and each was either assayed for the amount 
of protein  (D)  and  the  specific binding of  [3H]folic acid 
(O)  or  immunoblotted  with  the  indicated  antibody. 
Greater than 90%  of the protein was in fractions 8-15, but 
these  fractions  contained just  34%  of the  [3H]folic acid 
(Table  I). The  bulk of the  [3H]folic acid was in the light 
Figure 1.  Distribution of rotate recep- 
tor and  receptor-bound [3H]folic  acid 
during  caveolae  purification  on  the 
first (A) and second (B) OptiPrep gra- 
dients. MA104 cells were incubated for 
1 h  at  37°C  in  the  presence  of 5  nM 
[3H]folic  acid. They were then chilled 
to 4°C, washed, and processed to purify 
caveolae.  Each  fraction  was  assayed 
for  either  total  protein  and  bound 
[3H]folic  acid  (graph)  or  immunode- 
tectable caveolin (Caveolin), folate re- 
ceptor (Folate  Receptor),  and ctathrin 
(Ctathrin). For the immunobtots, each 
lane was loaded with all of the protein 
in  the  fraction.  (A)  Analysis of frac- 
tions from the first OptiPrep gradient. 
(B) Analysis of fractions from the sec- 
ond OptiPrep gradient. The data pre- 
sented in A  and  B  were generated in 
separate experiments. 
Smart et ah Clustered Folate  Receptor  in Caveolae  l 171 Table 1. Distribution of [3H]Folic Acid during Fractionation  ~6o 
DPM  DPM  t~ - 
Protein  yield  yield 
Sample  Protein  Folate  Protein  yield  (PNS)  (PM)  ~"  t~- 
mg  pmol  pmol/mg  %  %  % 
PNS  3.08  8.85  2.87  100  100  w0- 
CYTO  2.16  0.22  0.1  70  2.5  ~' 
IM  0.315  1.27  4.03  10  14  ~  s0-  o 
PM  0.506  5.49  10.85  16  62  100  ~  ~  ~0- 
NCM  0.461  1.86  4.03  15  21  34  ® 
CM  0.023  3.44  150  0.7  39  63  40- 
0"-- 
MAI04 cells were incubated in the presence of 5 nM [3H]folic acid for 1 h at 37°C. 
Cells were then processed to isolate caveolae as described. Each fraction was assayed 
for the amount of protein and the quantity of [3H]folic acid. PNS, postnuclear supema- 
tant; CYTO, cytosol (fractions 1-3 Percoll gradient); IM, intemal membranes (frac- 
tions,  5-25 Percoll gradient); PM, plasma membrane (fraction 4  Percoll  gradient); 
NCM, noncaveolae membrane (fractions  8-15, OptiPrep 1); CM, caveolae membrane 
(fraction 2, OptiPrep 2). 
membrane  fractions  (1-7).  Immunoblotting showed  that 
these same fractions contained nearly all the caveolin (Ca- 
veolin) and folate receptor (Folate Receptor) but no clath- 
rin (Clathrin).  A  further enrichment  in bound folate was 
obtained when we pooled fractions 1-7 from a second ex- 
periment  and used them to prepare the caveolae fraction 
(Fig. 1 B). While protein was detected in most of the frac- 
tions (D), the highest amount was in fraction 2. Fraction 2 
contained all of the detectable  [3H]folic acid ((3), caveolin 
(Caveolin),  and  folate  receptor  (Folate  Receptor).  In  a 
third experiment, we tabulated the amount of protein and 
[3H]folic acid in each step of the purification protocol (Ta- 
ble I). The caveolae fraction typically contained ~65%  of 
the original plasma membrane-bound [3H]folic acid with a 
specific binding of 140-150 pmol/mg of protein, which cor- 
responds  to  a  15-fold enrichment  relative  to the  plasma 
membrane. 
The  quantity  of bound  [3H]folic  acid  in  the  caveolae 
fractions  suggests  that  both  cell  surface  and  internalized 
receptors are present. This was confirmed (Fig. 2) by mea- 
suring the specific [3H]folic acid in caveolae fractions iso- 
lated  from cells  labeled  with  [3H]folic acid  under  condi- 
tions that detect either internal or external populations of 
receptor  (11).  Caveolae  fractions from cells incubated  at 
37°C for  1 h  had  a  specific  [3H]folic acid binding  of 150 
pmol/mg of protein  and  contained  69%  of the  folic acid 
initially associated with the membrane fraction (Control). 
If the incubation was carried out at 4°C, which only labels 
surface receptors (11), the specific binding was reduced by 
50%  (4°C Binding),  but  the  fraction  still  contained  the 
same  percentage  of total  membrane  associated  [3H]folic 
acid (68%). The caveolae fraction from cells incubated at 
37°C, chilled, and acid stripped (Acid Strip) to remove all 
[3H]folic acid bound to external  receptors  also had 50% 
of the  control  [3H]folic acid  and  the  same  percentage  of 
membrane-associated  label (64%). Finally, the amount of 
[3H]folic acid in the caveolae fraction (70%  of membrane 
bound) was unchanged in cells stripped  of surface-bound 
[3H]folic acid but warmed to 37°C (Acid Strip + 37°C) for 1 h. 
Clustered Receptors and 
5-Methyltetrahydrofolate  Delivery 
The concentration  of [3H]folic acid in the  caveolae frac- 
20- 
Control  4°C  Acid  Acid  Strip  Cold  Folic 
Binding  Strip  +  Acid 
37oc 
Figure 2.  Both internal and external folate receptors are in the 
caveolae fraction. MA104 cells were incubated either at 37°C (Con- 
trol, Cold Folic Acid, Acid Strip, Acid Strip+ 37°C) or at 4°C (4°C 
Binding) for 1 h in the presence of 5 nM [3H]folic acid. Cells were 
either used immediately (Control and 4°C Binding) or chilled  to 
4°C and acid stripped (Acid Strip, Acid Strip +37°C). One set of acid- 
stripped cells was incubated further at 37°C for 1 h. The percent- 
age of recovery of membrane-bound [3H]folic acid in the respec- 
tive  caveolae  fractions  was: control,  69%; 4°C binding, 68%; acid 
stripped, 64%; acid stripped+37°C, 70%; and cold folic acid, 70%. 
tion is consistent with previous morphologic observations 
showing clustered folate receptors associated with invagi- 
nated  caveolae  (24).  Cells  with  unclustered  receptors 
should have a  reduced amount of bound [3H]folic in iso- 
lated  caveolae.  Cholesterol-binding  drugs  such  as  filipin 
partially uncluster folate receptors on the surface of form- 
aldehyde-fixed cells (23). Therefore, we identified  a  con- 
centration of filipin that was not toxic to cells, as judged by 
trypan blue exclusion. We incubated cells in the presence 
of filipin for 15 min before adding [3H]folic acid to the dish 
and further incubating 1 h at 37°C. Filipin had no effect on 
total  [3H]folic acid binding,  indicating the receptors were 
not inactivated by the drug (compare PM in Table I with 
Table II). By contrast, we observed a >50% loss of bound 
[3H]folic acid from the caveolae fraction and a reciprocal 
Table H. Effects of Filipin on Distribution of Folate Receptor 
DPM  DPM 
Protein  yield  yield 
Sample  Protein  Folate  Protein  yield  (PNS)  (PM) 
mg  pmol  pmol/mg  e/c  %  % 
PNS  2.51  7.24  2.88  100  100 
CYTO  1.78  0.11  0.06  71  1.5 
IM  0.2  0.94  4.7  8  13 
PM  0.4  5.43  13.6  16  75  100 
NCM  0.39  3.64  9.33  16  50  67 
CM  0.025  1.77  71  1  24  32 
MA 104 cells were preincubated in the presence of 10 &g/ml filipin for 15 min before 
5 nM [3H]folic acid was added, and the cells were incubated an additional 1 h at 37°C. 
Cells were then processed to isolate caveolae as described. Each fraction was assayed 
for the amount of protein and the quantity [3H]folic acid. PNS, postnuclear superna- 
tant; CYTO, cytosol (fractions 1-3 Percoll gradient); IM, internal membranes (frac- 
tions 5-25 Percoll gradient); PM, plasma membrane (fraction 4  Percoll gradient); 
NCM, noncaveolae membrane (fractions 8-15, OptiPrep I); CM, caveolae membrane 
(fraction 2, OptiPrep 2). 
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(compare Table I with Table II). Filipin did not affect the 
amount of protein recovered in each fraction. 
Immunoblotting also detected an altered distribution of 
folate receptors  in  filipin-treated  cells  (Fig.  3).  This  was 
best  seen in  immunoblots of the  fractions from the  first 
OptiPrep gradient where all of the protein in each fraction 
is loaded on the gel. In untreated cells, the majority of the 
receptor migrated in  the  light membrane fractions (frac- 
tions 1-7) used to purify and concentrate caveolae (Con- 
trol). Filipin treatment caused the receptor distribution to 
shift toward the bottom of this gradient (Filipin) into frac- 
tions containing  the bulk of the membrane proteins (see 
Fig.  1).  Previously, we showed that immunogold labeling 
detected clustered receptors in PMA-treated cells (29). In 
contrast  to  filipin,  PMA  treatment  did  not  reduce  the 
number of folate receptors (PMA)  in  the  caveolae frac- 
tion. Therefore, two different assays (immunoblotting and 
folic acid  binding)  detected  filipin-induced  movement of 
folate  receptors  from  the  caveolae  fraction  to  fractions 
containing the bulk of the plasma membrane. 
Both functional folate receptors (22) and a caveolae in- 
ternalization cycle (29) appear to be required for the up- 
take of physiologic concentrations of 5-methyltetrahydro- 
folate.  An  essential  function  for clustered  receptors  has 
not been determined. The ability of filipin to uncluster the 
folate receptor provided a potential tool for assessing this 
requirement (Fig. 4).  Cells were either not treated (Con- 
trol) or incubated in the presence of filipin (Filipin) before 
measuring  [3H]folic  acid  internalization.  Ordinarily,  the 
ratio of internal to external bound [3H]folic acid in MA104 
cells is HI (Control). In filipin-treated cells, however, this 
ratio was reduced by ~50%. A  similar inhibition of recep- 
tor  internalization  was  seen  in  cells  exposed  to  PMA 
(PMA), a drug that prevents caveolae internalization with- 
out unclustering receptors (PMA; Fig. 3). 
Another activity of cholesterol-binding drugs is to disas- 
semble the caveolae coat (25). A more specific tool for un- 
clustering  GPI-anchored  receptors  may be  anti-receptor 
mAbs. Jemmerson and Agree (9) showed that the choice 
of  mAb  used  to  localize  GPI-anchored  alkaline  phos- 
phatase affects the localization of the protein. Some anti- 
bodies give a  dispersed  distribution,  while  others  give a 
clustered pattern. Mayor et al. (18) reported that cells in- 
cubated  in  the  presence  of  mAb  anti-folate  receptor 
Figure 3.  Filipin shifts the folate receptor from caveolae to the 
bulk membrane fractions. MA104 cells were  either not  treated 
(Control), incubated for 15 rain in the presence of 10 Ixg/ml filipin 
(Filipin),  or incubated in the presence of 1 ~M PMA for 1 h  at 
37°C. At the end of the treatment, plasma membranes were puri- 
fied and  processed  for  OptiPrep  1  gradients according to  stan- 
dard methods. The total protein from each fraction was loaded 
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Figure 4.  Filipin inhibits internalization  of [3H]folic acid. MA104 
cells were incubated in the presence of media alone for 1 h (Con- 
trol), 1 IxM PMA (PMA) for 1 h, or 10 Ixg/ml  filipin for 15 min be- 
fore the addition  of 5 nM [3H]folic acid and an additional  1-h in- 
cubation at  37°C. At  the  end  of the  incubations,  the  ratio  of 
internal to external receptors was measured as described. All val- 
ues are the average of six trials +SD. 
Movl9 had dispersed receptors, but after further incuba- 
tion in the presence of an anti-mouse IgG, the receptors 
appeared clustered over caveolae. To measure the effect 
of Movl9 on receptor distribution  (Fig. 5 A), cells were 
incubated in the presence or absence of different combina- 
tions of antibodies for 1 h 37°C,  and the receptor distribu- 
tion  was  assayed by immunoblotting  fractions  from  the 
first OptiPrep gradient. Compared to untreated cells (Con- 
trol), Movl9 (Movlg) shifted a substantial number of the 
receptors to the bulk membrane fractions. Cells incubated 
in  the  presence  of  both  Movl9  and  anti-mouse  IgG 
(Movl9 + 2°Ab), by contrast, had the same receptor dis- 
tribution  as  untreated  cells (compare with control).  The 
anti-mouse IgG alone (2°Ab) did not affect the receptor 
distribution.  Finally,  another  mAb  anti-folate  receptor 
designated  Movl8 did  not shift the  receptor distribution 
(Movl8). 
To see  how Movl9  affected the  distribution  of bound 
[3H]folic acid, MA104 cells were incubated for 1 h at 37°C 
in  the  presence  or  absence  of  Movl9  before  adding 
[3H]folic acid to the dish for an additional  1 h  (Fig. 5 B). 
Caveolae were isolated and the amount of bound [3H]folic 
acid was measured. Untreated cells (Control)  had a  spe- 
cific binding of ~150 pmol/mg of protein in the caveolae 
fraction, while Movl9-treated cells had only ~75 pmol/mg 
of protein (Mov19)  in this fraction. The antibody had no 
effect on the distribution  of caveolin or the total protein 
content of the fractions (data not shown). As was observed 
for filipin treatment (Table II), the [3H]folic acid lost from 
the caveolae fraction was shifted to the noncaveolae frac- 
tion  (Table  III). If the  cells were incubated  sequentially 
with  Movl9  and  anti-mouse  IgG (Mov19  + 2°Ab),  the 
specific binding of [3H]folic acid in the  caveolae fraction 
returned to control values. The anti-mouse IgG alone had 
no effect (2°Ab), and neither did Movl8 (Mov18). 
Movl9 also inhibited [3H]folic acid internalization (Fig. 
6 A). Cells were incubated in the presence of either Mov19 
(Mov19),  Movl9  +  anti-mouse  IgG  (Mov19  + 2°Ab), 
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DPM  DMP 
Protein  yield  yield 
Sample  Protein  Folate  Protein  Yield  (PNS)  (PM) 
mg  pmol  pmol/mg  %  %  % 
PNS  2.76  8.69  3.15  100  100 
CYTO  1.98  0.13  0.07  71  1.5 
IM  0.21  1.08  5.14  8  12 
PM  0.44  6.52  14.82  16  75  100 
NCM  0.44  4.44  10.09  16  51  68 
CM  0.029  2.12  73  1  24  32 
MA 104 cells were preincubated in the presence of 10 I~g/ml Mov 19 for 60 min before 
5 nM [3H]folic acid was added, and the cells were incubated an additional 1 h at 37~C. 
Cells were then processed to isolate caveolae as described. Each fraction was assayed 
for the amount of protein and the quantity of [3H]folic acid. PNS, posmuclear superna- 
tant; CYTO, cytosol (fractions 1-3 Percoll gradient); IM, internal membranes (frac- 
tions 5-25 Percoll gradient); PM,  plasma membrane (fraction 4  Percoll gradient); 
NCM, noncaveolae membrane (fractions 8-15, OptiPrep 1); CM, caveolae membrane 
(fraction 2, OptiPrep 2). 
Figure 5.  Effect of Mov19 on the distribution of either the folate 
receptor  (A) or bound  [3H]folic acid in the  plasma membrane 
(B). MA104 cells were  incubated  in the  absence  (Control) or 
presence of 10 ixg/ml of the indicated antibody for 1 h at 37°C. 
(A) Plasma membranes were prepared, sonicated, and separated 
on OptiPrep 1 gradient. The total protein from each fraction was 
loaded on gels and immunoblotted with mAb anti-folate receptor 
Movl9.  (B)  Cells were  incubated  in  the  presence  of  5  nM 
[3H]folic acid for 1 h at 37°C before caveolae fractions were col- 
lected from OptiPrep 2 gradients. 
anti-mouse IgG alone (2°Ab),  or Mov18 (Movl8)  before 
assaying for the internal to external bound [3H]folic  acid 
ratio.  Only Mov19 inhibited  internalization.  Movl9 also 
blocked  the  delivery  of 5-[3H]methyltetrahydrofolate to 
the  cytoplasm (Fig.  6  B).  After a  3-h  incubation  in  the 
presence (I) or absence ([]) of the mAb, control cells had 
taken up ~2 pmol/mg of protein,  while cells  exposed to 
Movl9 only accumulated 0.4 pmol/mg. PMA inhibited up- 
take to the same extent (©). 
Folate Delivery to Cytoplasm by Caveolae 
Biochemical (11) and morphologic (24) studies have failed 
to detect folate receptors in endosomes of MA104 cells. 
Previously,  we  used  Percoll  fractionation  to  show  that 
5-[3H]methyltetrahydrofolate  moves  directly  from  the 
plasma membrane to the cytosol of the cell, and the block- 
age of this step by monensin (11). To be sure we could de- 
tect movement of a ligand to internal membranes with this 
procedure, we tested 125I-transferrin.  MA104 cells were in- 
cubated in the presence of 125I-transferrin  for 1 h  at 4°C, 
and one set was assayed immediately while the other was 
warmed to 37°C for 0.5 h (Fig. 7). Initially, most of the cell- 
associated  radioactivity  was  found  in  the  plasma  mem- 
brane fraction (Plasma  Membrane;  open bar). The small 
amount in the cytosol fraction most likely was 125I-trans- 
ferrin  that  had  dissociated  from  the  receptor  (Cytosol; 
open bar). After 0.5 h at 37°C, there was a 25% decline in 
the  plasma  membrane  radiolabel  (Plasma  Membrane; 
compare open bar with solid bar) and a corresponding in- 
crease  in  the  125I-transferrin  associated with  the  internal 
membrane  fraction  (Internal  Membrane;  compare  open 
bar with solid bar). Therefore, the Percoll gradient proce- 
dure detects ligand movement from the plasma membrane 
to endosomes. This suggests that we would have detected 
the  movement  of  5-[3H]methyltetrahydrofolate through 
endosomes if this were the route to the cytoplasm. 
We  used  125I-transferrin  and  5-[3H]methyltetrahydro  - 
folate to identify inhibitors that might distinguish between 
the two internalization pathways. In MA104 cells,  uptake 
of 5-methyltetrahydrofolate is inhibited by PMA (29). Kap- 
fan et al. (14) showed that transferrin internalization is in- 
hibited  by phenylarsine  oxide  (PAO).  Cells  were  incu- 
bated in the presence of 0.32  ~g/ml of 125I-transferrin  for 
various times at 37°C before total cell membranes (plasma 
membrane and internal membranes) were separated from 
cytosol (Fig. 8 A). There was an immediate increase in 1251- 
transferrin  associated  with  the  membrane  fraction  that 
reached a plateau after 1 h of incubation ([]). We did not 
detect  a  significant  amount  of radiolabel  in  the  cytosol 
during  the  incubation  (11). Cells  that  were  exposed  to 
PAO during the incubation with ~25I-transferrin  had 50% 
less radiolabel associated with the membrane fraction (A), 
indicating that receptor internalization  and recycling was 
blocked. Replacing the PAO with PMA caused a slight in- 
crease  in  membrane-associated  radioactivity  (©).  While 
PAO inhibited the uptake of ~25I-transferrin,  it had no ef- 
fect on the internalization of 5-[3H]methyltetrahydrofolate 
(Fig. 8 B). Neither the internalization of membrane-bound 
vitamin (compare ~  with ©) nor the delivery to the cyto- 
plasm (compare •  with •  on the ordinate) was affected by 
PAO. 
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Figure 6.  Effect of Movl9 on the internal to external folate re- 
ceptor ratio (A) and the uptake of 5-[3H]methyltetrahydrofolate 
(B). (A) MA104 cells were incubated in the absence (Control) or 
presence of 10 ixg/ml of the indicated antibody for 1 h at 37°C. 
[3H]folic acid (5 nM) was added to the dish and the cells were in- 
cubated an additional 1 h. At the end of the incubation, cells were 
chilled to 4°C and assayed for acid resistant (internal) and acid la- 
bile (external receptors) [3H]folic acid. (B) MA104 cells were in- 
cubated in media alone ([]) or in media that contained either l0 
I~g/ml of  Movl9  (11) or  1  p.M  PMA  (O).  5-[3H]methyltetra  - 
hydrofolate (10 nM) was added to the dish, and the cells were 
incubated for the  indicated time. The  presence of excess cold 
5-methyltetrahydrofolate  blocked  uptake  of  5-[3H]methyltet  - 
rahydrofolate (0). All values are the average of six trials -+SD. 
Discussion 
One  of  the  unresolved  questions  about  potocytosis  has 
been the exact route the receptor takes during the inter- 
nalization cycle. We have used cell fractionation to better 
understand this pathway. A  method for isolating caveolae 
was used that previously has been shown, by both immu- 
noblotting (17, 20, 32)  and PAGE  (32), to yield a  unique 
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125I-transferrin  Figure  7.  migrates  to  internal  membranes. 
MA104 cells were incubated for 30 min in the presence of 0.32 
ixg/ml ]25I-transferrin  at 4°C. The cells were washed and either 
not warmed (open column) or warmed for 30 min (solid column). 
Cells were processed to isolate cytosol, plasma membrane, and 
internal  membranes  from  Percoll  gradients as  described. The 
amount  of  125I-transferrin  in  each  of these  fractions was  then 
measured. All values are the average of four trials _+SD. 
population of membranes.  While no membrane  purifica- 
tion procedure could ever yield an absolutely pure prepa- 
ration  of  caveolae,  the  results  we  obtained  with  this 
method are consistent with previous biochemical (11) and 
morphologic (24) studies that localized the cycle to caveolae 
membrane  in  MA104  cells.  We  were  able  to  recover 
:,-65% of the bound folate in the caveolae fraction and de- 
tect  both  internal  and  external  populations  of receptor. 
Since  all receptors appear to be functional in  these cells 
(11),  the  35%  associated  with  noncaveolae  membrane 
must be able to move into caveolae before internalization. 
Neither the folate receptor nor 5-methyltetrahydrofolate 
was  found  in  endosomes  during  receptor recycling even 
though 125I-transferrin movement to this compartment was 
easily detected. Furthermore, inhibitors that interfere with 
the clathrin-coated pit pathway did not affect the internal- 
ization of folate. These results affirm (4) that potocytosis is 
a distinct endocytic pathway. 
Ligand-binding studies detect opened and closed caveolae 
compartments,  but  electron microscopic immunogold  la- 
beling cannot  distinguish between  the two. Furthermore, 
immunoelectron microscopy failed to find folate receptors 
associated with endosomes in these cells (24).  In the cur- 
rent  study,  caveolae with  sequestered  receptors  (closed) 
and  caveolae with receptors accessible at the cell surface 
(open) were in the same caveolae fraction (Fig. 2). There- 
fore,  either  the  closed  caveolae  that  internalize  folate 
never detach from the plasma membrane or they become 
plasmalemmal vesicles with the same density as caveolae 
membrane  and, as a  consequence,  migrate identically on 
the gradients. Treatment of cells with PMA stimulates the 
disappearance of invaginated caveolae and  the return  of 
internalized receptors to the cell surface (29). Yet, by cell 
fractionation, the caveolae membrane in these cells is in- 
distinguishable from  caveolae in untreated  cells (Fig. 3). 
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Figure 8.  Effect of PAO and PMA on the uptake of either 125I- 
transferrin  (A) or 5-[3H]methyltetrahydrofolate  (B).  (A) In the 
presence of 0.32 ixg/ml 125I-transferrin, MA104 cells were incu- 
bated in media that contained  either  no additions  ([~, II), 1 ixM 
PMA (O), or 20 ~zM PAO (A) for the indicated  time at 37°C. At 
the end of the incubation,  total membrane ([3, O, A) or cytosol 
associated (11) 125I-transferrin was measured. (B) In the presence 
of 10 nM 5-[3H]methyltetrahydrofolate,  MA104 cells were incu- 
bated in media that contained either no additions  (D, II) or 20 
IxM PAO  (A, &)  for the  indicated  times.  Membranes (B,  ~) 
were separated from cytosol (11, A), and the amount of 5-[SH]me  - 
thyltetrahydrofolate was measured in each fraction.  All  values 
are the average of six trials _+SD. 
This means caveolae membrane must have physical char- 
acteristics that are independent of membrane shape. The 
flask-shaped membrane originally designated as caveolae 
(34) may correspond to the subset of caveolae membrane 
captured  by  the  fixation  process  during  internalization. 
The remaining caveolae, which  have the  same lipid  and 
protein composition, cannot be distinguished  in thin-sec- 
tion images from other segments of membrane. This con- 
clusion is supported by rapid-freeze, deep-etch images of 
fibroblast membranes showing many uninvaginated caveo- 
lae decorated with a caveolar coat (25). Caveolae membrane 
may constitute  a  much  larger percentage  of the  plasma 
membrane than thin-section morphology indicates. 
Filipin caused an ~50% decline in number of folate re- 
ceptors in the caveolae fraction (Fig. 3). After this treat- 
ment, approximately two-thirds of the receptors were in 
the bulk membrane fraction. This suggests that the drug 
does not completely uncluster folate receptors. Immuno- 
fluorescence images also indicate filipin only partially un- 
clusters the receptor in fixed cells (see Fig.  1)  (23).  Fur- 
thermore, we were forced to use a lower concentration of the 
drug in the current study to keep the cells alive. Therefore, 
the biochemical and the immunofluorescence results agree. 
Clustered folate receptors appear to be required for the 
efficient internalization of folate (Figs. 4, 5 B, and 6, A and 
B).  Two different  treatments  that  partially  unclustered 
the  receptor  inhibited  the  potocytosis  of  5-[3H]methyl  - 
tetrahydrofolate by decreasing the internalization of recep- 
tors.  Receptor  clustering  has  also  been  found  to  be  re- 
quired  for  receptor-mediated  endocytosis  by  clathrin- 
coated pits  (2).  The percentage of folate receptors clus- 
tered in caveolae (65%) is nearly the same as the portion 
of low density  lipoprotein  receptors  (50-70%)  found  in 
coated pits (3). Thus, the aggregation of receptors over a 
membrane domain specialized for internalization appears 
to be a common mechanism for guaranteeing efficient up- 
take of a ligand. The mechanism of folate receptor cluster- 
ing, however, is distinctly different than for the low density 
lipoprotein receptor. The targeting of receptors to clath- 
rin-coated  pits  depends  on  protein-protein  interactions 
between a specific amino acid sequence in the cytoplasmic 
tail and clathrin-associated coat proteins (8). The cluster- 
ing of GPI-anchored proteins in caveolae, by contrast, ap- 
pears to depend  on lipid-lipid  interactions  (23,  27).  The 
lipid  anchor  may convey high  mobility on  GPI proteins 
when they are in noncaveolae membrane and low mobility 
in glycolipid/cholesterol-rich caveolae. As a consequence, 
the GPI protein spends more time in caveolae and, at the 
steady state, is predominantly clustered. 
A  dynamic  GPI-anchored  protein,  shuttling  between 
caveolae and noncaveolae membrane, would  explain the 
unexpected effect of Movl9. Previous morphologic studies 
(18),  together with  the  current  biochemical experiments 
(Fig. 5 A), indicate that after this anti-folate receptor mAb 
binds, the receptors are partially dispersed in the plane of 
the  membrane.  The  morphologic  (18)  and  fractionation 
experiments (Fig. 5 A) also agree that when the cells are 
incubated in the presence of both the mAb and an anti- 
mouse IgG, the receptors are clustered in caveolae. Cell 
fractionation (Fig. 5 A) further shows that receptors from 
untreated  cells  are  clustered  in  caveolae,  which  agrees 
with the recent observation that GPI proteins inserted into 
the plasma membrane of lymphocytes spontaneously clus- 
ter (33). Therefore, the Mov19 must alter the normal, clus- 
tered pattern  of the  folate receptor. The mAb could  do 
this in two ways: (a) it may bind to receptors migrating in 
noncaveolae membrane and prevent their return to caveolae. 
(b) Alternatively, the mAb might bind to clustered recep- 
tors and cause them to disperse in the plane of the mem- 
brane. Regardless of the actual mechanism, not all mAbs 
against GPI proteins seem to uncluster (Fig. 5 A) (9). 
The effect of the mAb anti-folate receptor on receptor 
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with a  GPI anchor. First, these proteins are not static on 
the  cell  surface.  They  can  gain  access  to  all  membranes 
contiguous with the plasma membrane. This property en- 
dows the GPI protein with the ability to shuttle informa- 
tion  between  caveolae  and  other  membrane  compart- 
ments. Second, protein ligands may trigger the movement 
of specific  GPI  proteins  to  new  locations in  the  plasma 
membrane. In some cases, the ligand may actually tether 
the GPI protein to a transmembrane protein located in a 
distant compartment (5). Finally, a lipid-dependent mech- 
anism of clustering in caveolae obviates the need for homo- 
meric protein-protein interactions to effect GPI-anchored 
organization  on  the  cell  surface.  This  may  explain  why 
clustered  GPI  proteins are difficult  to detect  in prefixed 
cells  (18,  21):  aldehyde-based  fixatives  are  notoriously 
poor for immobilizing lipids in the plane of the membrane. 
Thus,  the  behavior of a  GPI-anchored  protein  does  not 
conform to standards previously established  from studies 
of transmembrane proteins. 
We have demonstrated how to use cell fractionation for 
studying potocytosis as well as the effects of a primary an- 
tibody on the membrane distribution  of a  GPI-anchored 
molecule. Our results are completely consistent with pre- 
vious biochemical (6, 9, 26,  27)  and morphologic (12,  18, 
23, 33) results on the behavior of this class of proteins. The 
detergent-free  caveolae  isolation  procedure  is  gentle 
enough  to  retain  ligands  bound  to  caveolae  in  cultured 
cells. Combined with Percoll fractionation, the movement 
of a ligand or its receptor from caveolae to other cellular 
compartments  can  be  followed.  Ligands  may  move  di- 
rectly  to  the  cytoplasm,  as  in  the  case  of 5-methyltetra- 
hydrofolate, or they may migrate to other membrane com- 
partments  such  as  the  ER  (30)  or endosomes  (21).  The 
isolation procedure is rapid enough to allow kinetic mea- 
surements of ligand movement. Combined with morpho- 
logic and other biochemical assays, this fractionation pro- 
cedure should be useful for identifying new molecules and 
ions that enter cells by potocytosis. 
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